Head of Analytical Development & Quality Control
US$234,500 – US$286,500 / yr base salary
Posted 12 Oct 2026
Advertised as “Head of Analytical Development & Quality Control ”
BranchFactor Summary
The original posting with the fluff stripped out
- Expected experience
- 12+ yrs
- Management level
- People management
| Base salary | US$234,500 – US$286,500 / yr |
|---|
Field of studyAnalytical Chemistry, Biochemistry, Biotechnology, Chemical Engineering, Pharmaceutical Sciences (or related)
Study levelMaster's or higher
The Head of Analytical Development & Quality Control will provide strategic and operational leadership for analytical development, characterization, method validation, transfer, and quality control activities supporting a growing pipeline of small molecule Oral Dose and parenteral Drug Product programs. The incumbent will have deep experience in analytical activities required to support early-stage to late-stage drug substance as well as oral solid dose and parenteral drug products. Additional experience in antibody/ADC manufacturing-focused analytical activities is desirable. This individual will be responsible for operating in a 100% outsourced environment to establish and will manage phase-appropriate analytical strategies from preclinical through commercialization, overseeing external analytical operations, and ensuring compliance with global regulatory expectations and GMP requirements for assigned programs.
As a key member of the Technical Operations team, this leader will collaborate cross-functionally with Medicinal Chemistry, Toxicology, Clinical Pharmacology, Drug Substance, Drug Product, , Regulatory Affairs, Quality Assurance, and external CDMOs/CROs/consultants to advance programs efficiently through development milestones while building scalable analytical and quality control capabilities for a rapidly growing organization.
Key Responsibilities
Analytical Development Leadership
-
Build and lead a small team of analytical development and quality control chemists capable of developing and executing phase-appropriate analytical method development and testing strategies and activities supporting Chemical and Drug Product development and eventual commercialization of the Treeline portfolio, including:
-
Phase-appropriate small molecule drug substance method development and testing
-
Phase-appropriate small molecule oral dose drug product method development and testing (tablets, capsules, gelcaps, pediatric formulations, etc.)
-
Phase-appropriate small molecule oral dose drug product intermediate method development and testing (e.g. amporphous solid dispersions)
-
Provide technical oversight for development, qualification, validation, and lifecycle management of analytical methods.
-
Ensure analytical methods support process development, formulation development, manufacturing, release testing, and regulatory submissions.
Quality Control Oversight
- Establish and lead QC strategies across clinical manufacturing operations
- Oversee external GMP testing activities including raw materials, IPCs, release testing and stability programs.